Deals and Financings
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Big-buck rounds of over $100m seem to be becoming the standard – rather than one-offs – in the medtech venture financing scene, with yet another two of these nine-figure transactions recorded in April. These mega rounds, together with the healthy deal volume seen that month, boosted total deal value to nearly $700m.
Latest From Deals
Philips has teamed up for the first time with the American Heart Association and the University of Pittsburgh Medical Center to set up a $30m venture capital fund that will invest in start-ups that are developing solutions to combat heart disease and stroke.
Medtech M&A activity dipped in April from last month but brought in a number of high-value acquisitions. Highlights included Fresenius, the world's largest dialysis firm, selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15bn to investment firm Summit Partners.
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech highlights notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we look at industry pacts that were sealed in March and April 2018.
Permira has signed a deal to acquire a majority stake in orthopedics group Corin from a group of investors for an undisclosed price.
Industry experts, investors and start-ups from across the pharma, biotech and medtech sectors gathered at the recent annual BioTrinity conference held in London to hear how the capital-raising climate is looking rosy for 2018, and to explore partnering and investment opportunities. Medtech Insight reports on predicted trends in health care and highlights two companies, Eyevensys and Rexgenero, that were presenting at the conference.
In this weekly feature, Medtech Insight presents a roundup of the previous week's M&A deals and venture financing rounds recorded in our M&A and VC Deal Trackers. This edition presents the transactions announced April 23-29, 2018.
Chinese medtech group MicroPort Scientific has bagged another cardiology deal this year, this time buying up its UK aortic valve repair partner Lombard Medical, which has run aground after failing to navigate itself out of financial troubles.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.